NNovo Nordisk Read More Can CagriSema Help Novo Nordisk Close the Gap With LLY in Obesity?2026-08-31 Novo Nordisk NVO is counting on CagriSema as one of its most important next-generation cardiometabolic assets. The once-weekly injectable…